Scancell Share Discussion Threads

[inanaco] 08/11/2017 15:07

Whats so frustrating ... is this

The Board of directors of Scancell have told you its undervalued, highlighting the need to validate values on both platforms to produce the Shareprice to warrant further cash raising from cash calls if that is the final source of finance. So for the next 3 4 months if Scancell can achieve that goal, as it's the preferred option, with plenty of cash in the bank to ride out any delay in the short term, then surely no instant cash call will be announced before hand, giving traders a window of a possible major uplift with little downside. Add in Ichor new gun submission to the FDA which allows SCIB1 to be used Global with full support and the potential release of patents .. it makes the case of buy and hold sensible, so why are the MM forcing big drops on small sells ?

think about it ..

[gooosed] 08/11/2017 14:57

chelsea35 - was it not the infamous Puritas that went several better and touted £12 . . . . . long gone and good riddance.

[inanaco] 08/11/2017 14:39

C7 your conflicted again .... you cannot support Moditope and immunobody as an industry and then portray £6 a share as pie in the sky even the Hardman report gives direction of value if you had the intelligence to understand it.

[torquayfan] 08/11/2017 14:24

C7 - yes you are totally transparent. We agree ! Whooppee !!
£1 £2 £3 £4 and zoom plus are more than possible.
So you might be surprised ?

Calm down and relax. TCOY. ATB

[chelsea35] 08/11/2017 12:54

Don"t worry inan £6 a share is coming lol.

[inanaco] 08/11/2017 12:15

yes that is why i see the contradictions in your posts C7 ..

Post my posts that conflict C7 as your now making further claims without substantial evidence which is what Tosh, does.

usual Drama Fiction writing ..

[chelsea35] 08/11/2017 12:00

Inanaco, my position has been totally transparent, yours sadly hasn"t.

[bermudashorts] 08/11/2017 11:48

Tosh,

Inanaco's right - Hygea have been sitting on Scancell profit (at varying levels) for years. Why haven't they sold?

[inanaco] 08/11/2017 11:24

chelsea352 Nov '17 - 11:31 - 12166 of 12196 0 0
Lozan, a pretty fair analysis, but for this continued buy, buy, buy SCAM, just a very flawed buy and hold strategy which thankfully i freed myself from long ago.

C7 make up your mind ..........

Your now telling Wildforce your holding tight ... ???

you seem to spend all your time trying to agree with every party depending on which BB you have engaged and who is posting, switching your position to suit ....

what is your policy .... "find a friend" to relieve boredom ?

[gooosed] 08/11/2017 11:01

wanderer1210 - crikey, another nugget of wisdom. Pace yourself, you don't want to over do it.

[tosh123] 08/11/2017 10:50

With the news from Hygea today, it would appear that their survival hinges on whether SCLP get funding as well.... Their numbers dont make for good reading at all...
As highlighted previously, im sure that there are a few very nervous fund managers out there, who wont be sending any Christmas Cards to RG unless something happens very soon.
What a lot of people dont realise is that its not only us Scancell holders that are hurting because of this shambles, there are also other investors that have indirect exposure via the VCT's.

[wanderer1210_0] 08/11/2017 10:34

Gooosed, to put it more simply for you, if there is no deal soon your investment here will have a remarkable similarity to your avatar

[gooosed] 08/11/2017 10:07

Right - same old story then. Thought there for a moment it was something new.

[tosh123] 08/11/2017 08:47

Wanderer... simple and factual... thats exactly what has been predicted.

[wanderer1210_0] 08/11/2017 06:21

Lack of funding, leading to a best case scenario of huge dilution at a huge discount to current share price The company need to pull a rabbit from the hat rather quickly now, AIM hates uncertainty and no matter how good the company or science is the result will be a plunging SP, AIMO

[gooosed] 07/11/2017 19:58

"world of hurt" ? Due to ?

[wanderer1210_0] 07/11/2017 17:01

Painful but predictable, the clock is now ticking, suitors know this, I'm rather dubious to will happen in the next few trading weeks before Xmas, I'm afraid a world of hurt is just around the corner imo

[chelsea35] 07/11/2017 16:46

painful to watch

[tosh123] 07/11/2017 16:21

and the slow continual slide continues... come on guys, give us some deal news !

[gooosed] 07/11/2017 08:54

The undernoted link posted on LSE yesterday featured a brief mention of Scancell.

In the pre-cursor to the mention, starting from approx. 2:32 John Vandermosten says "Aah well, we've seen a couple of names that Merck are quite interested in" then goes on to name Scancell.

Ramping or fact - who knows.

[chelsea35] 05/11/2017 20:01

Well i rather fancy a decent week leading up to a Moditope RNS very soon. Thats what took the share up to 64p not inanaco, and i am pretty sure when Calculas bought at 6p and sold some at 32p they didn"t ask for inanacos advice either, nor did those recognising the brilliance of LD, OR the likes of Keith Flaherty.

More importantly the seven patients exceeding five years survival didn"t either. Agree with the FT tip and positive AGM the spikes would never be a rerate. Patent Approval in Moditope, IND submission for SCIB 1 Combo Trial and securing funding for trials will re rate the share. An important week with the Divisional Application for Moditope Patent on Wednesday, yes i rather fancy a period of inflection RNSs each one definitive to scheduled trials. AIMHO

[chelsea35] 05/11/2017 04:05

"Broken record"..........now those were the days.